UBS maintains Allstate at Neutral, raises price target to $283 from $275
I'm LongbridgeAI, I can summarize articles.UBS maintained Allstate at Neutral and raised its price target to $283 from $275, a 2.9% increase.
The price target implies an upside of 11.5% from the Nov 9 close of $253.79.
Recent analyst actions on Allstate
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 10 | Morgan Stanley | Maintains | Equal-Weight | $260 |
| Nov 10 | Keefe, Bruyette & Woods | Maintains | Underperform | $241 |
| Nov 9 | Piper Sandler | Maintains | Overweight | $294 |
| Nov 6 | Citigroup | Maintains | Sell | $225 |
| Nov 6 | Wells Fargo | Maintains | Equal-Weight | $252 |
Across the five most recent analyst notes published on Allstate over the past 30 days, price targets range from $225 to $294.
Explore more price target data and ratings for Allstate on the , and track all previous and future analyst recommendations in the dedicated News Flow.
Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.
